Nuo Shi (诺仕)诺仕
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂
主要成分Active Ingredients
- 十一酸睾酮Shiyi Suangao Tong
药物知识说明
十一酸睾酮是一种在国家药监局注册认定的药品。标注生产企业为浙江医药股份有限公司新昌制药厂。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂、浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂、浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 诺仕) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 浙江医药股份有限公司新昌制药厂.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂, 浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂, 浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 诺仕Recorded Chinese name: 诺仕
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 40mg40 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10970240
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10970240
Manufacturer
Chinese legal name: 浙江医药股份有限公司新昌制药厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10970240
生产企业
浙江医药股份有限公司新昌制药厂(国产)
适应症
本品适用于:|1.原发性或继发性睾丸功能减退.|2.男孩体质性青春期延迟.|3.乳腺癌转移的姑息性治疗.|4.再生障碍性贫血的辅助治疗.|5.中老年部分雄性激素缺乏综合征.|6. 类风湿性关节炎.
用法用量
口服，必须在专科医生指导下使用。开始剂量按每日120～160mg，用药二周后，每日40～120mg的剂量维持。早晚两次，饭后口服，若每天服用的胶囊成单数，可在早上多服1粒，或遵医嘱。
不良反应
1.多毛、痤疮、阴茎异常勃起、精子减少、精液量减少、水钠潴留。|2.青春期前男孩性早熟或骨骺早闭。|3.偶见胃肠不适或过敏反应。
禁忌
前列腺癌、乳腺癌患者及可疑者禁用.
注意事项
1.发生严重不良反应时，应立即停止治疗，待症状消失后，再从较低的剂量重新开始.|2.病人如有心力衰竭(包括无症状型)?肾功能衰竭、前列腺肥大、高血压、癫痫或三叉神经痛(或有上述疾病史者)慎用，应严密观察，因雄激素可能引起水钠潴留.|3.青春期前男孩应慎用，以免骨骺早闭或性早熟.|4.有水肿倾向的肾脏病、心脏病患者慎用.
贮藏
密闭，在凉暗干燥处保存。
规格
40mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.